Knight Therapeutics Inc.

12:11 PM EST - Knight Therapeutics Inc. : Reported financial results for the year ended December 31, 2018. Revenues were $12,500, an increase of $3,866 or 45% over prior year. Realized net gain on financial assets measured at fair value through profit or loss of $6,444. Net income was $24,079, an increase of $6,835 or 40% versus prior year. Knight Therapeutics Inc. shares T.GUD are trading down $0.02 at $7.51.